⌕
MeiraGTx Holdings · MGTX · Nasdaq
Tenet 63 · Solid
Compare
$9.18+4.44%At closeTenet 63 · Solid
$9.18+0.39 (+4.44%)
At close: Nov 13, 2026, 4:00 PM ET· Nasdaq · USD

MeiraGTx Holdings (MGTX) Stock

MeiraGTx Holdings (MGTX) closed at $9.18 on Nov 13, 2026; its Tenet Score is 63 of 100 against 409 Healthcare peers.

Sources Company filings, market prices and computed by Tenet Filings, prices and TenetScore as of How we compute thisNot investment advice

Key stats

Previous close
$9.18
Nov 13, 2026
Market cap
$897.2M
share price × the latest quarter's diluted weighted-average share count (vendor)
P/E
11.9×
price ÷ trailing EPS, Nov 13, 2026 close
Dividend yield
0.00%
reinvests all
52-week range
6.62 – 15.35
low → high
Tenet Score
63/100
Solid · 409 Healthcare peers

Industry: Drugs · see every company filed here →

MeiraGTx Holdings plc scores 63/100. Solid. Strongest on value and quality, trading at 12× earnings versus 409 Healthcare peers.

Tenet Score · vs sector

n=409
63/ 100
Solid
Fundamental composite — rates the business, not the timing.
Each metric's standing vs the company's own record is shown on the Statistics tab.
Value
78
Quality
66
Health
53
Growth
53

Factor grades

Grid rings: 25 · 50 · 75 · 100 percentile
ValueBQualityCHealthCGrowthCMomentumC
A grade is a label over the shown score. Value/Quality/Health/Growth are sector percentiles; Momentum ranks 12−1 return across the equity universe — a lens, never folded into the Tenet Score.
Show the math →

Price

Loading chart…
P/B
4.2×
cap ÷ Sep 30, 2026 book value, Nov 13, 2026 close
P/S
11.0×
price to fiscal 2025 sales
ROE
215%
TTM through Sep 30, 2026
Operating margin
−130.2%
fiscal 2025, before interest and tax
Net margin
46.1%
TTM through Sep 30, 2026
Current ratio
4.62
Sep 30, 2026 balance sheet
Net debt / EBITDA
—
Not meaningful: EBITDA is zero or negative.
EPS CAGR 5y
—
This growth figure starts in a period outside the history your plan includes.

The whole report, at a glance · every card is a live peek, click any to open the section

About MeiraGTx Holdings plc

MeiraGTx Holdings plc, a clinical stage gene therapy company, focusing on developing treatments for patients with serious diseases. The company develops various therapies for ocular diseases, including inherited blindness, as well as Xerostomia following ra…

Composite computed Nov 16, 2026 · peer basis: Healthcare (n=409) · every glimpse links to its full section with sources · not investment advice.

ETF exposure

held by 59 US ETFs · top wrappers by weightSee all ETFs holding MGTX →

Similar-sized companies in Drugs

The 10 companies in this industry closest in market cap, as of Nov 13, 2026.

What sector and industry is MeiraGTx Holdings in?

MeiraGTx Holdings is in the Healthcare sector and the Drugs industry.

What is MeiraGTx Holdings' Tenet Score?

MeiraGTx Holdings' Tenet Score is 63 out of 100, ranked against 409 Healthcare peers as of Nov 16, 2026.

Install Tenet on your phone

Tenet home pageMethodology© 2026 Tenet Investing Inc.

Data from Intrinio and Financial Modeling Prep.